Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of recombinant Mycobacterium tuberculosis fusion protein (EC) skin test in adults aged 65 years and older
ChiCTR2400084976Phase 4Recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of C-Tb in Tuberculosis (TB) (2 arms), sponsored by Shenzhen Third People's Hospital. Primary endpoints: Red halo transverse and longitudinal diameter, Induration transverse and longitudinal diameter and 2 more. Started May 2024; status: recruiting.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2400084976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084976.